Researchers in the College of Agriculture, Health and Natural Resources recently conducted a novel study assessing knowledge of and interest in a new injectable form of PrEP (pre-exposure prophylaxis) among men who have sex ...
May 22, 2023
0
2
Genetic alterations that give rise to a rare, fatal disorder known as MOGS-CDG paradoxically also protect cells against infection by viruses. Now, scientists at the Lewis Katz School of Medicine at Temple University have ...
May 19, 2023
0
52
People living with HIV remain at higher risk than people living without HIV for developing various cancers that can be treated with immune checkpoint inhibitors (ICIs). Since people living with HIV may have dysfunctional ...
May 17, 2023
0
40
An international study led by MELIS-UPF researchers from the Infection Biology and Molecular Virology laboratories has identified and characterized Schlafen 12 (SLFN 12) as a novel HIV restriction factor. SLFN 12 shuts down ...
May 10, 2023
0
82
New research from Northwestern University has shown that educating couples, rather than individuals, may be a highly effective strategy to end the HIV epidemic.
May 10, 2023
0
1
New research from Boston Medical Center found that people living with HIV that have had pulmonary tuberculosis had broader and more potent HIV antibody responses and differences in HIV sequences predicted to be antibody resistant ...
May 9, 2023
0
21
Living with HIV is certainly a very big deal. It has detrimental mental health impacts on people. Such impacts are even worse for mothers living with HIV whose children are also living with HIV.
May 8, 2023
0
2
Nearly 40% of participants in a pilot study quit tobacco after completing a video-based smoking cessation intervention developed by a University of Massachusetts Amherst community health researcher for HIV-positive smokers ...
May 3, 2023
0
10
Gene-editing therapy aimed at two targets—HIV-1, the virus that causes AIDS, and CCR5, the co-receptor that helps the virus get into cells—can effectively eliminate HIV infection, new research from the Lewis Katz School ...
May 1, 2023
0
128
A cohort study of persons with confirmed mpox infections who were treated with the novel antiviral tecovirimat has found that the HIV status of the patients did not impact treatment outcomes. The findings are published in ...
May 1, 2023
0
12
